nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketobemidone—UGT1A9—Irinotecan—pancreatic cancer	0.227	0.258	CbGbCtD
Ketobemidone—CYP2B6—Tamoxifen—pancreatic cancer	0.0936	0.106	CbGbCtD
Ketobemidone—CYP2B6—Irinotecan—pancreatic cancer	0.0718	0.0817	CbGbCtD
Ketobemidone—CYP2C8—Tamoxifen—pancreatic cancer	0.0709	0.0805	CbGbCtD
Ketobemidone—CYP2C8—Erlotinib—pancreatic cancer	0.0602	0.0685	CbGbCtD
Ketobemidone—CYP2C19—Tamoxifen—pancreatic cancer	0.0594	0.0676	CbGbCtD
Ketobemidone—CYP2C8—Fluorouracil—pancreatic cancer	0.0522	0.0594	CbGbCtD
Ketobemidone—CYP2C9—Tamoxifen—pancreatic cancer	0.0494	0.0562	CbGbCtD
Ketobemidone—CYP2B6—Doxorubicin—pancreatic cancer	0.0392	0.0446	CbGbCtD
Ketobemidone—CYP2C9—Fluorouracil—pancreatic cancer	0.0364	0.0414	CbGbCtD
Ketobemidone—CYP3A4—Tamoxifen—pancreatic cancer	0.0287	0.0327	CbGbCtD
Ketobemidone—CYP3A4—Erlotinib—pancreatic cancer	0.0244	0.0278	CbGbCtD
Ketobemidone—CYP3A4—Irinotecan—pancreatic cancer	0.0221	0.0251	CbGbCtD
Ketobemidone—CYP3A4—Docetaxel—pancreatic cancer	0.0162	0.0184	CbGbCtD
Ketobemidone—CYP3A4—Sunitinib—pancreatic cancer	0.0161	0.0183	CbGbCtD
Ketobemidone—CYP3A4—Doxorubicin—pancreatic cancer	0.0121	0.0137	CbGbCtD
Ketobemidone—OPRK1—Signaling Pathways—HES1—pancreatic cancer	3.34e-05	0.000277	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.33e-05	0.000277	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TERT—pancreatic cancer	3.33e-05	0.000277	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—STK11—pancreatic cancer	3.3e-05	0.000274	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—TYMP—pancreatic cancer	3.29e-05	0.000274	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—STK11—pancreatic cancer	3.29e-05	0.000273	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GLP1R—pancreatic cancer	3.26e-05	0.000271	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—DPYD—pancreatic cancer	3.2e-05	0.000267	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—PIK3CB—pancreatic cancer	3.19e-05	0.000266	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—HIF1A—pancreatic cancer	3.19e-05	0.000265	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TSC2—pancreatic cancer	3.18e-05	0.000264	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—APOE—pancreatic cancer	3.11e-05	0.000259	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	3.1e-05	0.000258	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.08e-05	0.000257	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—CXCL8—pancreatic cancer	3.07e-05	0.000255	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—KDR—pancreatic cancer	3.05e-05	0.000254	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	3.04e-05	0.000253	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.01e-05	0.00025	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.98e-05	0.000248	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.97e-05	0.000247	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TERT—pancreatic cancer	2.92e-05	0.000243	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GLP1R—pancreatic cancer	2.91e-05	0.000242	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.9e-05	0.000242	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—NFKBIA—pancreatic cancer	2.9e-05	0.000241	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—SMAD4—pancreatic cancer	2.89e-05	0.00024	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—NOTCH1—pancreatic cancer	2.87e-05	0.000239	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PRSS1—pancreatic cancer	2.86e-05	0.000238	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—DPYD—pancreatic cancer	2.86e-05	0.000238	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	2.86e-05	0.000238	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—TYMS—pancreatic cancer	2.83e-05	0.000235	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—APOE—pancreatic cancer	2.82e-05	0.000235	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—HES1—pancreatic cancer	2.82e-05	0.000234	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PIK3CG—pancreatic cancer	2.81e-05	0.000234	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—NRAS—pancreatic cancer	2.81e-05	0.000234	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—HIF1A—pancreatic cancer	2.8e-05	0.000232	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TSC2—pancreatic cancer	2.79e-05	0.000232	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CD44—pancreatic cancer	2.78e-05	0.000231	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—EGF—pancreatic cancer	2.78e-05	0.000231	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—APOE—pancreatic cancer	2.73e-05	0.000227	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	2.71e-05	0.000226	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.71e-05	0.000226	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	2.7e-05	0.000225	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.69e-05	0.000223	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—KDR—pancreatic cancer	2.67e-05	0.000222	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.67e-05	0.000222	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GCG—pancreatic cancer	2.67e-05	0.000222	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GLP1R—pancreatic cancer	2.65e-05	0.00022	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.65e-05	0.00022	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—DPYD—pancreatic cancer	2.61e-05	0.000217	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CXCL8—pancreatic cancer	2.59e-05	0.000216	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.59e-05	0.000216	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—EGFR—pancreatic cancer	2.56e-05	0.000213	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PIK3CG—pancreatic cancer	2.55e-05	0.000212	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—NFKBIA—pancreatic cancer	2.54e-05	0.000211	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—NOTCH1—pancreatic cancer	2.52e-05	0.000209	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—STK11—pancreatic cancer	2.51e-05	0.000209	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ARG2—pancreatic cancer	2.48e-05	0.000206	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	2.47e-05	0.000206	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TERT—pancreatic cancer	2.47e-05	0.000205	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PIK3CD—pancreatic cancer	2.47e-05	0.000205	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PIK3CG—pancreatic cancer	2.46e-05	0.000205	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—NRAS—pancreatic cancer	2.46e-05	0.000205	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PPARG—pancreatic cancer	2.46e-05	0.000204	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.45e-05	0.000204	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.45e-05	0.000203	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—EGF—pancreatic cancer	2.43e-05	0.000202	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—KRAS—pancreatic cancer	2.42e-05	0.000201	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.36e-05	0.000197	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—HIF1A—pancreatic cancer	2.36e-05	0.000196	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.36e-05	0.000196	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TSC2—pancreatic cancer	2.36e-05	0.000196	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CD44—pancreatic cancer	2.35e-05	0.000196	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—APOE—pancreatic cancer	2.31e-05	0.000192	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.31e-05	0.000192	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—APOE—pancreatic cancer	2.3e-05	0.000191	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.28e-05	0.00019	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—KDR—pancreatic cancer	2.26e-05	0.000188	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GCG—pancreatic cancer	2.26e-05	0.000188	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—EGFR—pancreatic cancer	2.24e-05	0.000187	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PIK3CD—pancreatic cancer	2.24e-05	0.000186	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—PIK3CA—pancreatic cancer	2.22e-05	0.000185	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.18e-05	0.000181	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—TYMP—pancreatic cancer	2.17e-05	0.00018	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PIK3CD—pancreatic cancer	2.16e-05	0.00018	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—TYMS—pancreatic cancer	2.16e-05	0.000179	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.15e-05	0.000179	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PIK3CB—pancreatic cancer	2.15e-05	0.000179	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NFKBIA—pancreatic cancer	2.15e-05	0.000179	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.14e-05	0.000178	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NOTCH1—pancreatic cancer	2.13e-05	0.000177	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—STK11—pancreatic cancer	2.12e-05	0.000177	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—KRAS—pancreatic cancer	2.12e-05	0.000176	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CD44—pancreatic cancer	2.1e-05	0.000175	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PIK3CG—pancreatic cancer	2.08e-05	0.000173	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—NRAS—pancreatic cancer	2.08e-05	0.000173	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PIK3CG—pancreatic cancer	2.07e-05	0.000173	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CXCL8—pancreatic cancer	2.07e-05	0.000172	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.06e-05	0.000171	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—EGF—pancreatic cancer	2.06e-05	0.000171	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—HRAS—pancreatic cancer	2.05e-05	0.000171	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.04e-05	0.00017	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GCG—pancreatic cancer	2.02e-05	0.000168	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PPARG—pancreatic cancer	2e-05	0.000167	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—AKT1—pancreatic cancer	2e-05	0.000166	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.99e-05	0.000166	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CASP3—pancreatic cancer	1.98e-05	0.000165	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PIK3CB—pancreatic cancer	1.95e-05	0.000162	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.95e-05	0.000162	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PTGS2—pancreatic cancer	1.93e-05	0.000161	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CCND1—pancreatic cancer	1.93e-05	0.00016	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CD44—pancreatic cancer	1.92e-05	0.000159	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CTNNB1—pancreatic cancer	1.91e-05	0.000159	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—EGFR—pancreatic cancer	1.9e-05	0.000158	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—STK11—pancreatic cancer	1.89e-05	0.000158	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PIK3CB—pancreatic cancer	1.89e-05	0.000157	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.88e-05	0.000156	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MMP9—pancreatic cancer	1.87e-05	0.000156	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.86e-05	0.000155	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PTEN—pancreatic cancer	1.86e-05	0.000155	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GCG—pancreatic cancer	1.84e-05	0.000153	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PIK3CD—pancreatic cancer	1.83e-05	0.000152	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—TYMS—pancreatic cancer	1.83e-05	0.000152	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PIK3CD—pancreatic cancer	1.82e-05	0.000152	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—AKT1—pancreatic cancer	1.81e-05	0.000151	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CXCL8—pancreatic cancer	1.81e-05	0.000151	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.81e-05	0.000151	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—HRAS—pancreatic cancer	1.8e-05	0.00015	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—KRAS—pancreatic cancer	1.79e-05	0.000149	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.78e-05	0.000148	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—APOE—pancreatic cancer	1.75e-05	0.000146	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—AKT1—pancreatic cancer	1.75e-05	0.000146	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.75e-05	0.000145	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CASP3—pancreatic cancer	1.74e-05	0.000144	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—STK11—pancreatic cancer	1.73e-05	0.000144	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—SRC—pancreatic cancer	1.72e-05	0.000143	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.72e-05	0.000143	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CCND1—pancreatic cancer	1.69e-05	0.000141	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PTEN—pancreatic cancer	1.69e-05	0.00014	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—VEGFA—pancreatic cancer	1.68e-05	0.00014	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CTNNB1—pancreatic cancer	1.67e-05	0.000139	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—STAT3—pancreatic cancer	1.66e-05	0.000138	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—NRAS—pancreatic cancer	1.66e-05	0.000138	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.65e-05	0.000137	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MMP9—pancreatic cancer	1.64e-05	0.000136	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.63e-05	0.000136	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PTEN—pancreatic cancer	1.63e-05	0.000136	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—TYMS—pancreatic cancer	1.63e-05	0.000136	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.62e-05	0.000135	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PIK3CB—pancreatic cancer	1.59e-05	0.000133	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—AKT1—pancreatic cancer	1.59e-05	0.000132	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PIK3CB—pancreatic cancer	1.59e-05	0.000132	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PIK3CG—pancreatic cancer	1.58e-05	0.000132	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PTGS2—pancreatic cancer	1.58e-05	0.000131	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MYC—pancreatic cancer	1.55e-05	0.000129	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TGFB1—pancreatic cancer	1.54e-05	0.000128	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CXCL8—pancreatic cancer	1.53e-05	0.000127	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PPARG—pancreatic cancer	1.53e-05	0.000127	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—HRAS—pancreatic cancer	1.52e-05	0.000127	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—SRC—pancreatic cancer	1.51e-05	0.000126	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—EGFR—pancreatic cancer	1.51e-05	0.000126	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—TYMS—pancreatic cancer	1.49e-05	0.000124	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—APOE—pancreatic cancer	1.49e-05	0.000124	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—AKT1—pancreatic cancer	1.48e-05	0.000123	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—VEGFA—pancreatic cancer	1.47e-05	0.000122	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CASP3—pancreatic cancer	1.47e-05	0.000122	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—STAT3—pancreatic cancer	1.46e-05	0.000121	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—NRAS—pancreatic cancer	1.45e-05	0.000121	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—KRAS—pancreatic cancer	1.43e-05	0.000119	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CCND1—pancreatic cancer	1.43e-05	0.000119	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CTNNB1—pancreatic cancer	1.41e-05	0.000118	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.41e-05	0.000117	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PIK3CD—pancreatic cancer	1.39e-05	0.000116	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MMP9—pancreatic cancer	1.39e-05	0.000115	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PTEN—pancreatic cancer	1.38e-05	0.000115	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PTEN—pancreatic cancer	1.37e-05	0.000114	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MYC—pancreatic cancer	1.35e-05	0.000113	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TGFB1—pancreatic cancer	1.35e-05	0.000112	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—AKT1—pancreatic cancer	1.34e-05	0.000112	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	1.34e-05	0.000111	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—APOE—pancreatic cancer	1.33e-05	0.00011	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—EGFR—pancreatic cancer	1.33e-05	0.00011	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PIK3CA—pancreatic cancer	1.31e-05	0.000109	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PPARG—pancreatic cancer	1.29e-05	0.000108	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—SRC—pancreatic cancer	1.28e-05	0.000106	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TP53—pancreatic cancer	1.27e-05	0.000106	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CD44—pancreatic cancer	1.26e-05	0.000105	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.25e-05	0.000104	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—KRAS—pancreatic cancer	1.25e-05	0.000104	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—VEGFA—pancreatic cancer	1.24e-05	0.000104	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—STAT3—pancreatic cancer	1.23e-05	0.000103	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NRAS—pancreatic cancer	1.23e-05	0.000102	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—HRAS—pancreatic cancer	1.21e-05	0.000101	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	1.21e-05	0.000101	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GCG—pancreatic cancer	1.21e-05	0.000101	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—APOE—pancreatic cancer	1.21e-05	0.000101	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PTGS2—pancreatic cancer	1.2e-05	0.0001	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	1.2e-05	9.95e-05	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PIK3CA—pancreatic cancer	1.19e-05	9.89e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	1.18e-05	9.8e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PPARG—pancreatic cancer	1.15e-05	9.6e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PIK3CA—pancreatic cancer	1.15e-05	9.57e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MYC—pancreatic cancer	1.15e-05	9.52e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.14e-05	9.52e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TGFB1—pancreatic cancer	1.14e-05	9.5e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—STK11—pancreatic cancer	1.14e-05	9.48e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—EGFR—pancreatic cancer	1.12e-05	9.32e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TP53—pancreatic cancer	1.11e-05	9.26e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	1.09e-05	9.07e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—AKT1—pancreatic cancer	1.07e-05	8.91e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—HRAS—pancreatic cancer	1.06e-05	8.85e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—KRAS—pancreatic cancer	1.06e-05	8.8e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PPARG—pancreatic cancer	1.05e-05	8.76e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	1.05e-05	8.75e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PTEN—pancreatic cancer	1.05e-05	8.72e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	1.03e-05	8.54e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PTGS2—pancreatic cancer	1.02e-05	8.46e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—TYMS—pancreatic cancer	9.8e-06	8.15e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PIK3CA—pancreatic cancer	9.72e-06	8.09e-05	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—AKT1—pancreatic cancer	9.71e-06	8.08e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PIK3CA—pancreatic cancer	9.69e-06	8.06e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	9.59e-06	7.98e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TP53—pancreatic cancer	9.4e-06	7.82e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—AKT1—pancreatic cancer	9.4e-06	7.82e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	9.17e-06	7.62e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PTGS2—pancreatic cancer	9.08e-06	7.55e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—HRAS—pancreatic cancer	8.99e-06	7.48e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PTEN—pancreatic cancer	8.87e-06	7.38e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	8.36e-06	6.95e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PTGS2—pancreatic cancer	8.28e-06	6.89e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—APOE—pancreatic cancer	7.97e-06	6.63e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—AKT1—pancreatic cancer	7.94e-06	6.61e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PTEN—pancreatic cancer	7.92e-06	6.59e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—AKT1—pancreatic cancer	7.92e-06	6.59e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	7.39e-06	6.15e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PTEN—pancreatic cancer	7.22e-06	6.01e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	7.19e-06	5.98e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PPARG—pancreatic cancer	6.94e-06	5.77e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	6.32e-06	5.26e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	6.26e-06	5.21e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—AKT1—pancreatic cancer	6.04e-06	5.02e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	5.59e-06	4.65e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	5.51e-06	4.58e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PTGS2—pancreatic cancer	5.46e-06	4.54e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—AKT1—pancreatic cancer	5.11e-06	4.25e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	5.1e-06	4.24e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PTEN—pancreatic cancer	4.76e-06	3.96e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—AKT1—pancreatic cancer	4.56e-06	3.8e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—AKT1—pancreatic cancer	4.16e-06	3.46e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	3.36e-06	2.79e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—AKT1—pancreatic cancer	2.75e-06	2.28e-05	CbGpPWpGaD
